Risk factor    Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study Lancet (2004);364:937-52 S. Yusuf, et al. Prevention Conference VII: Obesity, a worldwide epidemic related to heart disease and stroke: Group I: worldwide demographics of obesity Circulation (2004);110:e463-70 D. A. York, et al. Inflammation as a cardiovascular risk factor Circulation (2004);109:II2-10 J. T. Willerson and P. M. Ridker Clinical and angiographic predictors of restenosis after stent deployment in diabetic patients Circulation (2004);109:867-73 N. E. West, et al. Relationship of physical fitness vs body mass index with coronary artery disease and cardiovascular events in women Jama (2004);292:1179-87 T. R. Wessel, et al. Relations of plasma total TIMP-1 levels to cardiovascular risk factors and echocardiographic measures: the Framingham heart study Eur Heart J (2004);25:1509-16 J. Sundstrom, et al. Relations of plasma matrix metalloproteinase-9 to clinical cardiovascular risk factors and echocardiographic left ventricular measures: the Framingham Heart Study Circulation (2004);109:2850-6 J. Sundstrom, et al. Impact of stenting and abciximab in patients with diabetes mellitus undergoing primary angioplasty in acute myocardial infarction (the CADILLAC trial) Am J Cardiol (2005);95:1-7 T. D. Stuckey, et al. Carotid artery plaque burden, stiffness, and mortality risk in elderly men: a prospective, population-based cohort study Circulation (2004);110:344-8 S. Stork, et al. High systolic blood pressure increases cardiovascular risk Circulation (2004);109:e9033-4 R. SoRelle C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study Circulation (2004);110:380-5 M. K. Rutter, et al. Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): case-control study Lancet (2004);364:953-62 A. Rosengren, et al. Obesity and the risk of death after acute myocardial infarction Am Heart J (2004);147:841-6 J. S. Rana, et al. Tissue plasminogen activator antigen and D-dimer as markers for atherothrombotic risk among healthy postmenopausal women Circulation (2004);110:292-300 A. D. Pradhan, et al. Type D personality predicts death or myocardial infarction after bare metal stent or sirolimus-eluting stent implantation: a Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry substudy J Am Coll Cardiol (2004);44:997-1001 S. S. Pedersen, et al. Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region Circulation (2004);110:2678-86 A. Patel, et al. Optimal low-density lipoprotein is 50 to 70 mg/dl: lower is better and physiologically normal J Am Coll Cardiol (2004);43:2142-6 J. H. O'Keefe, Jr., et al. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey Circulation (2004);109:42-6 J. K. Ninomiya, et al. Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention Am J Cardiol (2004);94:300-5 E. Nikolsky, et al. Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy Circulation (2004);109:2273-8 I. Moussa, et al. Association of diabetes mellitus and glycemic control strategies with clinical outcomes after acute coronary syndromes Am Heart J (2004);147:246-52 D. K. McGuire, et al. Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women: a report from the Women's Ischemia Syndrome Evaluation Circulation (2004);109:714-21 O. C. Marroquin, et al. Leukocyte count and coronary heart disease: implications for risk assessment J Am Coll Cardiol (2004);44:1945-56 M. Madjid, et al. Framingham risk score and prediction of lifetime risk for coronary heart disease Am J Cardiol (2004);94:20-4 D. M. Lloyd-Jones, et al. Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring Jama (2004);291:2204-11 D. M. Lloyd-Jones, et al. Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus: relationships to cardiovascular disease and risk factor intervention Circulation (2004);109:2524-8 H. S. Lim, et al. Anemia is an independent predictor of mortality after percutaneous coronary intervention J Am Coll Cardiol (2004);44:541-6 P. C. Lee, et al. Effect of diabetes and associated conditions on long-term survival after coronary artery bypass graft surgery Circulation (2004);110:II41-4 B. J. Leavitt, et al. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease N Engl J Med (2004);350:2549-57 S. Klein, et al. Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Found Circulation (2004);110:2952-67 S. Klein, et al. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes Circulation (2004);110:32-5 K. Klausen, et al. Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study Circulation (2004);109:706-13 K. E. Kip, et al. Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease Circulation (2004);109:2175-80 S. Kiechl, et al. Concept and usefulness of cardiovascular risk profiles Am Heart J (2004);148:16-26 W. B. Kannel, et al. Differential mortality risk of postprocedural creatine kinase-MB elevation following successful versus unsuccessful stent procedures J Am Coll Cardiol (2004);44:1210-4 A. Jeremias, et al. Relation of response of subclinical atherosclerosis detected by electron beam tomography to baseline low-density lipoprotein cholesterol levels Am J Cardiol (2004);93:101-3 H. S. Hecht and S. M. Harman Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines J Am Coll Cardiol (2004);44:720-32 S. M. Grundy, et al. Assessing low levels of high-density lipoprotein cholesterol as a risk factor in coronary heart disease: a working group report and update J Am Coll Cardiol (2004);43:717-24 A. M. Gotto, Jr. and E. A. Brinton New risk factors for atherosclerosis and patient risk assessment Circulation (2004);109:III15-9 J. C. Fruchart, et al. The distribution of 10-Year risk for coronary heart disease among US adults: findings from the National Health and Nutrition Examination Survey III J Am Coll Cardiol (2004);43:1791-6 E. S. Ford, et al. Cardiovascular risk factors for stable angina pectoris versus unheralded myocardial infarction Am Heart J (2004);147:502-8 K. Dunder, et al. Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis J Am Coll Cardiol (2004);44:1812-8 R. Deo, et al. Favorable cardiovascular risk profile in young women and long-term risk of cardiovascular and all-cause mortality Jama (2004);292:1588-92 M. L. Daviglus, et al. Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary intervention J Am Coll Cardiol (2004);43:8-14 R. A. Corpus, et al. Volumetric analysis of in-stent intimal hyperplasia in diabetic patients treated with or without abciximab: results of the Diabetes Abciximab steNT Evaluation (DANTE) randomized trial Circulation (2004);109:861-6 A. J. Chaves, et al. Irbesartan but not amlodipine suppresses diabetes-associated atherosclerosis Circulation (2004);109:1536-42 R. Candido, et al. Effect of carotid atherosclerosis screening on risk stratification during primary cardiovascular disease prevention Am J Cardiol (2004);93:1030-2 R. L. Bard, et al. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study Circulation (2004);109:837-42 C. M. Ballantyne, et al. HDL cholesterol and protective factors in atherosclerosis Circulation (2004);109:III8-14 G. Assmann and A. M. Gotto, Jr. Impact of insulin-requiring diabetes mellitus on effectiveness of reperfusion and outcome of patients undergoing primary percutaneous coronary intervention for acute myocardial infarction Am J Cardiol (2004);93:1170-2 D. Antoniucci, et al. Combined effects of smoking and hypercholesterolemia on inflammatory process, thrombosis/fibrinolysis system, and forearm hyperemic response Am J Cardiol (2004);94:1181-4 C. Antoniades, et al. The pathophysiology of cigarette smoking and cardiovascular disease: an update J Am Coll Cardiol (2004);43:1731-7 J. A. Ambrose and R. S. Barua Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial Circulation (2004);110:1572-8 D. Aguilar, et al. Clinically unrecognized Q-wave myocardial infarction in patients with diabetes mellitus, systemic hypertension, and nephropathy Am J Cardiol (2004);94:337-9 D. Aguilar, et al.